Published in Proc Natl Acad Sci U S A on November 01, 1971
Prevention of neonatal hyperbilirubinemia by tin protoporphyrin IX, a potent competitive inhibitor of heme oxidation. Proc Natl Acad Sci U S A (1981) 2.04
The porphyrias: a review. J Clin Pathol (1972) 1.28
Motor neuropathy in porphobilinogen deaminase-deficient mice imitates the peripheral neuropathy of human acute porphyria. J Clin Invest (1999) 1.14
The liver excretes large amounts of heme into bile when heme oxygenase is inhibited competitively by Sn-protoporphyrin. Proc Natl Acad Sci U S A (1985) 1.03
Hepatic heme metabolism and its control. Yale J Biol Med (1979) 1.02
Lon peptidase 1 (LONP1)-dependent breakdown of mitochondrial 5-aminolevulinic acid synthase protein by heme in human liver cells. J Biol Chem (2011) 0.99
Liver transplantation in the management of porphyria. Hepatology (2014) 0.97
RNAi-mediated silencing of hepatic Alas1 effectively prevents and treats the induced acute attacks in acute intermittent porphyria mice. Proc Natl Acad Sci U S A (2014) 0.95
Postulated deficiency of hepatic heme and repair by hematin infusions in the "inducible" hepatic porphyrias. Proc Natl Acad Sci U S A (1977) 0.93
Secretion of haem by hepatic parenchymal cells. Biochem J (1979) 0.93
Pathogenesis and treatment of acute intermittent porphyria: discussion paper. J R Soc Med (1983) 0.90
Repression by hematin of porphyrin biosynthesis in erythrocyte precursors in congenital erythropoietic porphyria. Proc Natl Acad Sci U S A (1974) 0.89
Brain 5-aminolaevulinate synthase. Developmental aspects and evidence for regulatory role. Biochem J (1981) 0.84
Circadian rhythms in acute intermittent porphyria--a pilot study. Eur J Clin Invest (2013) 0.82
Preclinical Development of a Subcutaneous ALAS1 RNAi Therapeutic for Treatment of Hepatic Porphyrias Using Circulating RNA Quantification. Mol Ther Nucleic Acids (2015) 0.80
Acute Hepatic Porphyria. J Clin Transl Hepatol (2015) 0.80
Effect of hematin on endothelial cells and endothelial cell-platelet interactions. Am J Pathol (1984) 0.78
Delta-aminolevulinic acid cytotoxic effects on human hepatocarcinoma cell lines. BMC Cancer (2002) 0.78
Sn-protoporphyrin suppresses chemically induced experimental hepatic porphyria. Potential clinical implications. J Clin Invest (1985) 0.77
Light-induced depigmentation in planarians models the pathophysiology of acute porphyrias. Elife (2016) 0.76
Differential effects of metalloporphyrins on messenger RNA levels of delta-aminolevulinate synthase and heme oxygenase. Studies in cultured chick embryo liver cells. J Clin Invest (1994) 0.76
Increased protoporphyrin in erythrocytes in a child with acute intermittent porphyria. Arch Dis Child (1977) 0.75
Heme status affects human hepatic messenger RNA and microRNA expression. World J Gastroenterol (2013) 0.75
Incorporation of haemoglobin haem into the rat hepatic haemoproteins tryptophan pyrrolase and cytochrome P-450. Biochem J (1986) 0.75
A case of variegate porphyria in association with coeliac disease and bisphosphonate associated dental osteonecrosis. J Clin Med Res (2009) 0.75
Heme as a Target for Therapeutic Interventions. Front Pharmacol (2017) 0.75
The induction in vitro of the synthesis of delta-aminolevulinic acid synthetase in chemical porphyria: a response to certain drugs, sex hormones, and foreign chemicals. J Biol Chem (1966) 5.70
Delta-aminolevulinic acid synthetase. II. Induction in rat liver. J Biol Chem (1966) 2.98
The synthesis of enzymes concerned in bacteriochlorophyll formation in growing cultures of Rhodopseudomonas spheroides. J Gen Microbiol (1960) 2.66
ACUTE INTERMITTENT PORPHYRIA: THE FIRST "OVERPRODUCTION DISEASE" LOCALIZED TO A SPECIFIC ENZYME. Proc Natl Acad Sci U S A (1965) 2.34
Heme biosynthesis in intermittent acute prophyria: decreased hepatic conversion of porphobilinogen to porphyrins and increased delta aminolevulinic acid synthetase activity. Proc Natl Acad Sci U S A (1970) 2.33
Studies on the biosynthesis of blood pigments. 2. Haem and porphyrin formation in intact chicken erythrocytes. Biochem J (1956) 2.11
The metabolism of delta -aminolaevulic acid. 1. Normal pathways, studied with the aid of 15N. Biochem J (1956) 1.98
Induction of -aminolevulinic acid synthetase in chick embryo liver cells in cluture. Proc Natl Acad Sci U S A (1970) 1.77
Steroid induction of porphyrin synthesis in liver cell culture. II. The effects of heme, uridine diphosphate glucuronic acid, and inhibitors of nucleic acid and protein synthesis on the induction process. J Biol Chem (1968) 1.76
Heme biosynthesis; on the incorporation of iron into protoporphyrin. Biochim Biophys Acta (1959) 1.67
Activity of amino-laevulinic acid synthetase in normal and porphyric human livers. Nature (1966) 1.57
THE EFFECT OF CARBOHYDRATE FEEDING ON THE INDUCTION OF DELTA-AMINOLEVULINIC ACID SYNTHETASE. Metabolism (1964) 1.51
THE CONVERSION OF HEMATIN TO BILIRUBIN FOLLOWING INTRAVENOUS ADMINISTRATION IN HUMAN SUBJECTS. J Clin Invest (1945) 1.46
Oscillations of hepatic delta-aminolevulinic acid synthetase produced in vivo by heme. Biochem Biophys Res Commun (1966) 1.46
Delta-aminolaevulinic acid synthetase activity in normal and porphyric human livers. S Afr Med J (1967) 1.39
Acute intermittent porphyria. New morphologic and biochemical findings. Am J Med (1966) 1.38
FACTORS AFFECTING THE EXCRETION OF PORPHYRIN PRECURSORS BY PATIENTS WITH ACUTE INTERMITTENT PORPHYRIA. I. THE EFFECT OF DIET. Metabolism (1964) 1.35
[Biochemical pathogenesis of acute intermittent porphyria]. Klin Wochenschr (1969) 1.16
Purification and properties of delta-aminolevulinate dehydratase from tissues of two strains of mice. J Biol Chem (1966) 1.05
Soluble hepatic delta-aminolevulinic acid synthetase: end-product inhibition of the partially purified enzyme. Proc Natl Acad Sci U S A (1969) 1.00
Control of haem synthesis by feedback inhibition on human-erythrocyte delta-aminolaevulate dehydratase. Biochem J (1966) 0.98
Oscillations of hepatic delta-aminolevulinic acid synthetase produced by estrogen: a possible role of "rebound induction" in biological clock mechanisms. Proc Natl Acad Sci U S A (1967) 0.92
Acute intermittent porphyria: effect of diet and griseofulvin. Medicine (Baltimore) (1967) 0.85
Presynaptic neuromuscular inhibition by porphobilinogen and porphobilin. Proc Natl Acad Sci U S A (1971) 0.85
Mechanism of inhibition by hemin of increase of delta-aminolevulinate synthetase in liver mitochondria. J Biochem (1970) 0.80
Quantitative evaluation of Escherichia coli host strains for tolerance to cytosine methylation in plasmid and phage recombinants. Nucleic Acids Res (1989) 7.78
Mast cell lines produce lymphokines in response to cross-linkage of Fc epsilon RI or to calcium ionophores. Nature (1989) 5.10
Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies. Psychopharmacology (Berl) (1997) 5.03
Reproductive cessation in female mammals. Nature (1998) 3.31
Anti-NMDA receptor encephalitis: report of ten cases and comparison with viral encephalitis. Eur J Clin Microbiol Infect Dis (2009) 3.11
Delta-aminolevulinic acid synthetase. II. Induction in rat liver. J Biol Chem (1966) 2.98
Role of ER export signals in controlling surface potassium channel numbers. Science (2001) 2.93
Suppression of epithelial apoptosis and delayed mammary gland involution in mice with a conditional knockout of Stat3. Genes Dev (1999) 2.91
The first linkage disequilibrium (LD) maps: delineation of hot and cold blocks by diplotype analysis. Proc Natl Acad Sci U S A (2002) 2.80
Tests and estimates of allelic association in complex inheritance. Proc Natl Acad Sci U S A (1998) 2.78
The problem of chronic refractory angina; report from the ESC Joint Study Group on the Treatment of Refractory Angina. Eur Heart J (2002) 2.68
How well are complete dentures copied? Br Dent J (1998) 2.58
Delta-aminolevulinic acid synthetase. I. Studies in liver homogenates. J Biol Chem (1966) 2.45
B cell stimulatory factor-1/interleukin-4 mRNA is expressed by normal and transformed mast cells. Cell (1987) 2.44
The optimal measure of allelic association. Proc Natl Acad Sci U S A (2001) 2.41
Recommendations for conducting the in vivo alkaline Comet assay. 4th International Comet Assay Workshop. Mutagenesis (2003) 2.29
Steady-state and dynamic properties of cardiac sodium-calcium exchange. Secondary modulation by cytoplasmic calcium and ATP. J Gen Physiol (1992) 2.25
Hardy-Weinberg quality control. Ann Hum Genet (1999) 2.22
Multicentre survey of radiologically inserted gastrostomy feeding tube (RIG) in the UK. Clin Radiol (2012) 2.04
The single cell gel electrophoresis assay (comet assay): a European review. Mutat Res (1993) 1.98
Tongue control of upper complete dentures: a clinical hint. Br Dent J (1991) 1.94
Stat6 is necessary and sufficient for IL-4's role in Th2 differentiation and cell expansion. J Immunol (2001) 1.93
Steady-state and dynamic properties of cardiac sodium-calcium exchange. Sodium-dependent inactivation. J Gen Physiol (1992) 1.92
Sildenafil (Viagra) prolongs cardiac repolarization by blocking the rapid component of the delayed rectifier potassium current. Circulation (2000) 1.91
Error filtration, interference, and the human linkage map. Proc Natl Acad Sci U S A (1991) 1.91
Standard maps of chromosome 10. Ann Hum Genet (1990) 1.77
Acute intermittent porphyria. A clinical and biochemical study of 46 patients. Medicine (Baltimore) (1970) 1.76
Prevalence and transmission of honeybee viruses. Appl Environ Microbiol (2006) 1.74
Identification of a peptide inhibitor of the cardiac sarcolemmal Na(+)-Ca2+ exchanger. J Biol Chem (1991) 1.72
Capillary LC-MS2 at the attomole level for monitoring and discovering endogenous peptides in microdialysis samples collected in vivo. Anal Chem (2001) 1.71
Heme synthetase deficiency in human protoporphyria. Demonstration of the defect in liver and cultured skin fibroblasts. J Clin Invest (1975) 1.70
Development of a prognostic model for grading chronic graft-versus-host disease. Blood (2001) 1.65
Non-disjunction of chromosome 18. Hum Mol Genet (1998) 1.62
Identification of a 200-kD, brefeldin-sensitive protein on Golgi membranes. J Cell Biol (1992) 1.61
Stat5 as a target for regulation by extracellular matrix. J Biol Chem (1995) 1.61
Factors affecting mammographic visualization of the breast after augmentation mammaplasty. JAMA (1992) 1.57
Improvement in early saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy: results of a Veterans Administration Cooperative Study. Circulation (1988) 1.57
Counting algorithms for linkage. Ann Hum Genet (1990) 1.56
Allelic association between marker loci. Proc Natl Acad Sci U S A (1999) 1.55
A map of the human genome in linkage disequilibrium units. Proc Natl Acad Sci U S A (2005) 1.54
Evidence that genetic susceptibility to Mycobacterium tuberculosis in a Brazilian population is under oligogenic control: linkage study of the candidate genes NRAMP1 and TNFA. Tuber Lung Dis (1997) 1.50
Quantitative Differentiation of Minute Amounts of the Coproporphyrin Isomers (I and III) Based on Fluorescence Behavior. Science (1946) 1.50
Cycle length dynamics at the onset of postinfarction ventricular tachycardias induced in canines: dependence on interval-dependent excitation properties of the reentrant substrate. J Cardiovasc Electrophysiol (2000) 1.48
Saphenous vein graft patency 1 year after coronary artery bypass surgery and effects of antiplatelet therapy. Results of a Veterans Administration Cooperative Study. Circulation (1989) 1.47
The serum porphobilinogen and hepatic porphobilinogen deaminase in normal and porphyric individuals. J Lab Clin Med (1971) 1.47
Vascular endothelial growth factor (VEGF) is released from platelets during blood clotting: implications for measurement of circulating VEGF levels in clinical disease. Clin Sci (Lond) (1998) 1.46
THE CONVERSION OF HEMATIN TO BILIRUBIN FOLLOWING INTRAVENOUS ADMINISTRATION IN HUMAN SUBJECTS. J Clin Invest (1945) 1.46
Glucose tolerance in Papua New Guinea: ethnic differences, association with environmental and behavioural factors and the possible emergence of glucose intolerance in a highland community. Med J Aust (1989) 1.46
Oscillations of hepatic delta-aminolevulinic acid synthetase produced in vivo by heme. Biochem Biophys Res Commun (1966) 1.46
Succinylacetone, a potent inhibitor of heme biosynthesis: effect on cell growth, heme content and delta-aminolevulinic acid dehydratase activity of malignant murine erythroleukemia cells. Biochem Biophys Res Commun (1979) 1.45
Lean body mass estimation by creatinine kinetics. J Am Soc Nephrol (1994) 1.44
Porphyria variegata and porphyria cutanea tarda in siblings: chemical and genetic aspects. Proc Natl Acad Sci U S A (1975) 1.43
Onset of manifestations of hepatic porphyria in relation to the influence of female sex hormones. Arch Intern Med (1966) 1.43
Radioimmunoassay of mammalian type-C polypeptides. IV. Characterization of woolly monkey and gibbon viral antigens. Int J Cancer (1973) 1.42
Normal caffeine consumption: influence on thermogenesis and daily energy expenditure in lean and postobese human volunteers. Am J Clin Nutr (1989) 1.42
A safe simple method for removal of the gallbladder through the umbilical trocar site during laparoscopic surgery. J Laparoendosc Surg (1994) 1.39
Successful use of size-mismatched liver allografts in children by delayed primary closure of the abdominal wall. Br J Surg (1996) 1.39
Potential dangers of laparoscopic insufflator. Lancet (1992) 1.39
The prevalence, aetiology and clinical significance of pseudo-sinusoidal fetal heart rate patterns in labour. Br J Obstet Gynaecol (1991) 1.39
German health system slow to change. Manag Care Q (1998) 1.39
Acute intermittent porphyria. New morphologic and biochemical findings. Am J Med (1966) 1.38
Is there really a 'male menopause'? Whatever the term, midlife changes warrant attention. Adv Nurse Pract (2000) 1.38
Hormonal requirements for the induction of cytochrome P-450 in hepatocytes cultured in a serum-free medium. Biochem Biophys Res Commun (1979) 1.38
A survey of complete denture prosthetics for the elderly, the handicapped and difficult patients. Br Dent J (1992) 1.37
Genetic epidemiology of early onset breast cancer. J Med Genet (1994) 1.37
The role of Stat3 in apoptosis and mammary gland involution. Conditional deletion of Stat3. Adv Exp Med Biol (2000) 1.34
Domperidone should not be considered a no-risk alternative to cisapride in the treatment of gastrointestinal motility disorders. Circulation (2000) 1.33
Mechanism of cardiac Na(+)-Ca2+ exchange current stimulation by MgATP: possible involvement of aminophospholipid translocase. J Physiol (1992) 1.33
Algorithms for a location database. Ann Hum Genet (1992) 1.33
Efficient BLG-Cre mediated gene deletion in the mammary gland. Transgenic Res (1998) 1.33
Coordinate synthesis of heme and apoenzyme in the formation of tryptophan pyrrolase. Science (1966) 1.32
Influence of vascular endothelial growth factor single nucleotide polymorphisms on tumour development in cutaneous malignant melanoma. Genes Immun (2002) 1.32
Dominant genes for colorectal cancer are not rare. Ann Hum Genet (1992) 1.30
The clinical porphyrias. Semin Hematol (1968) 1.28
Novobiocin; an inhibitor of the repair of UV-induced but not X-ray-induced damage in mammalian cells. Nucleic Acids Res (1979) 1.26
A model for calculating messenger RNA half-life: short lived messenger RNA in the induction of mammalian delta-aminolevulinic acid synthetase. Biochem Biophys Res Commun (1965) 1.26
A red cell enzyme method for the diagnosis of acute intermittent porphyria. Blood (1974) 1.26
Immunogenetics of leishmanial and mycobacterial infections: the Belem Family Study. Philos Trans R Soc Lond B Biol Sci (1997) 1.25
NF-kappaB inhibits apoptosis in murine mammary epithelia. J Biol Chem (2000) 1.25
Epicardial and endocardial mapping of ventricular tachycardia in patients with myocardial infarction. Is the origin of the tachycardia always subendocardially localized? Circulation (1991) 1.25
Developing a plan for primary health care facilities in Soweto, South Africa. Part I: Guiding principles and methods. Health Policy Plan (1996) 1.24
Human hepatic delta-aminolaevulinate synthase: requirement of an exogenous system for succinyl-coenzyme A generation to demonstrate increased activity in cirrhotic and anticonvulsant-treated subjects. Clin Sci Mol Med (1977) 1.24
Regulation of the sheep beta-lactoglobulin gene by lactogenic hormones is mediated by a transcription factor that binds an interferon-gamma activation site-related element. Mol Endocrinol (1994) 1.24
Seizure management in acute hepatic porphyria: risks of valproate and clonazepam. Neurology (1980) 1.23
Inhibition of lung injury, inflammation, and interstitial pulmonary fibrosis by polyethylene glycol-conjugated catalase in a rapid inhalation model of asbestosis. Am Rev Respir Dis (1990) 1.22
13q deletion anatomy and disease progression in patients with chronic lymphocytic leukemia. Leukemia (2010) 1.21
The optimal measure of linkage disequilibrium reduces error in association mapping of affection status. Hum Mol Genet (2004) 1.21
Is circulating endotoxin the trigger for the systemic inflammatory response syndrome seen after injury? Ann Surg (1997) 1.19
Effect of hematin in acute porphyric relapse. Ann Intern Med (1973) 1.19